Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) announced that it will provide a live webcast of its upcoming Investor/Analyst Day on Thursday, October 13, 2011 at 10:00am EDT. Members of Rigel's senior management team will provide an overview of the company's product pipeline, as well as discuss the Phase 2 strategy for R343, their inhaled syk inhibitor for asthma.
Read the full article and the disclaimer at:http://bestotc.com/18697/stock-alerts/rigl-crwe-furx-cyno-stocks-to-watch-by-bestotccom/
(RIGL, CRWE, FURX, CYNO) Stocks to Watch by BestOtc.com
October 12th, 2011 at 09:46 am